|
English
|
正體中文
|
简体中文
|
總筆數 :0
|
|
造訪人次 :
51713215
線上人數 :
873
教育部委託研究計畫 計畫執行:國立臺灣大學圖書館
|
|
|
"chun ming hong"的相關文件
顯示項目 1-10 / 23 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
| 臺大學術典藏 |
2021-12-14T23:11:55Z |
Drug resistance profile and clinical features for hepatitis C patients experiencing DAA failure in Taiwan
|
CHUN-MING HONG; Lin, You Yu; CHUN-JEN LIU; Lai, Ya Yun; Shiou-Hwei Yeh; HUNG-CHIH YANG; JIA-HORNG KAO; Hsu, Shih Jer; Huang, Yi Hsiang; Yang, Sheng Shun; Kuo, Hsing Tao; Cheng, Pin Nan; Yu, Ming Lung; PEI-JER CHEN |
| 臺大學術典藏 |
2021-06-25T08:10:16Z |
Addition of ribavirin to daclatasvir plus asunaprevir for chronic hepatitis C 1b patients with baseline NS5A resistance-associated variants improved response
|
CHUN-MING HONG; Liu C.-J.; Yeh S.-H.; Chen P.-J. |
| 臺大學術典藏 |
2021-06-25T08:10:15Z |
Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:15Z |
Sofosbuvir-based Interferon-Free Direct Acting Antiviral Regimens for Heart Transplant Recipients with Chronic Hepatitis C Virus Infection
|
Liu C.-H.; Chen Y.-S.; Wang S.-S.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:15Z |
A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients
|
Liu C.-H.; Liu C.-J.; CHUN-MING HONG; Su T.-H.; Yang H.-C.; Chen K.-M.; Huang Y.-P.; Yeh Y.-M.; Tien H.-L.; Liu Y.-C.; Kao J.-H.; Chen D.-S.; Chen P.-J. |
| 臺大學術典藏 |
2021-06-25T08:10:14Z |
Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study
|
Liu C.-H.; Huang Y.-J.; Yang S.-S.; Chang C.-H.; Yang S.-S.; Sun H.-Y.; Liu C.-J.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:14Z |
Generic velpatasvir plus sofosbuvir for hepatitis C virus infection in patients with or without human immunodeficiency virus coinfection
|
Liu C.-H.; Sun H.-Y.; Liu C.-J.; Sheng W.-H.; Hsieh S.-M.; Lo Y.-C.; Liu W.-C.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Hung C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:13Z |
Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection
|
Liu C.-H.; Su T.-H.; Liu C.-J.; CHUN-MING HONG; Yang H.-C.; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:13Z |
Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan
|
Liu C.-H.; Liu C.-J.; Su T.-H.; Yang H.-C.; CHUN-MING HONG; Tseng T.-C.; Chen P.-J.; Chen D.-S.; Kao J.-H. |
| 臺大學術典藏 |
2021-06-25T08:10:13Z |
NIACE score refines the overall survival of hepatocellular carcinoma by Barcelona clinic liver cancer staging
|
Su T.-H.; Liao S.-H.; CHUN-MING HONG; Liu C.-J.; Tseng T.-C.; Liu C.-H.; Yang H.-C.; Chen P.-J.; Chen D.-S.; Chen C.-L.; Adhoute X.; Bourlière M.; Kao J.-H. |
顯示項目 1-10 / 23 (共3頁)
1 2 3 > >>
每頁顯示[10|25|50]項目
|
